Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1091-1100 of 9364

Page
per page
  1. Aztreonam
    A5931 Aztreonam
    Summary: Monobactam antibiotic,selectively active against Gram-negative aerobic bacteria
      insoluble in EtOH; ≥10.24 mg/mL
  2. Irbesartan
    A5970 Irbesartan
    Target: Angiotensin AT1 Receptors
    Summary: Angiotensin II inhibitor
  3. Tie2 kinase inhibitor
    A5979 Tie2 kinase inhibitor
    Target: Tie-2
    Summary: Tie-2(Tie2 ) inhibitor
      ≥22 mg/mL
  4. PD168393
    A2024 PD168393
    Target: PDGFR|FGFR|EGFR|PKC|insulin
    Summary: EGFR inhibitor
  5. 10058-F4
    A1169 10058-F4
    Summary: C-Myc-Max dimerization inhibitor
      ≥24.9 mg/mL
  6. Stattic
    A2224 Stattic
     5 Citation
    Target: STAT
    Summary: STAT3 inhibitor,small-molecule and potent
      insoluble in H2O; insoluble in EtOH; ≥10.56 mg/mL
  7. T0901317
    A2249 T0901317
    Target: Liver X receptors (LXRs)
    Summary: Liver X receptor agonist,potent and selective
      ≥24.05 mg/mL
  8. MEK162 (ARRY-162, ARRY-438162)
    A1947 MEK162 (ARRY-162, ARRY-438162)
    Target: MEK
    Summary: MEK1/2 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; insoluble in DMSO
  9. AG-18
    A1173 AG-18
    Summary: EGFR/PDGFR inhibitor
  10. AZD3514
    A1372 AZD3514
    Summary: Androgen receptor downregulator
      ≥24.45 mg/mL

Items 1091-1100 of 9364

Page
per page